Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
  • Breaking News
  • Health
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español
No Result
View All Results
Vitals Today
No Result
View All Results

Policy » Andalusia invests 4.2 million euros in promoting hematologic cancer treatments

Andalusia invests 4.2 million euros in promoting hematologic cancer treatments

Andalusia is promoting innovation in the treatment of hematological cancers with a €4.2 million project focused on more effective and less expensive CAR-T therapies.

by Wendy Lazcano
March 16, 2025
Reading time: 2 mins read
A hand in a clinical setting holds several tubes and syringes, surrounded by laboratory equipment and personal protective equipment, with a background of metallic surfaces and visible pharmaceuticals.

Andalusian Government

Share on BlueskyShare on TwitterShare on Linkedin
  • Author
  • Recent Posts
Wendy Lazcano
Editor at Vitals Today
She is an experienced journalist who has worked in print media such as Diario de Cuba and Review Energy, as well as hosting radio (Wradio/Grupo PRISA) and television (Canal 33) programs. A specialist in politics and regulations, Wendy stands out for her ability to analyze and explain complex issues.
Latest posts by Wendy Lazcano (see all)
  • What is vortioxetine and what is this antidepressant prescribed for? - October 7, 2025
  • Ketoconazole Shampoo: How to Use It Correctly for Dandruff and Dermatitis? - October 6, 2025
  • What is the best time to take Hydroferol to absorb it better? - October 3, 2025

Andalusia has launched a project to improve CAR-T (Chimeric Antigen Receptor T-Cell) therapies in the treatment of hematological cancers.

According to government information, this initiative, called CART_ANDALUCÍA, is part of the Public Procurement of Innovation (CPI) strategy in the Andalusian public health system.

A step towards more effective and accessible therapies

The project seeks to develop an improved version of CAR-T therapies, making them more effective, less toxic, and more affordable. The main objective is to overcome the current challenges of CAR-T treatments, such as lack of response in some patients and high toxicity.
Furthermore, the aim is to improve the persistence of therapeutic effects and reduce the high costs associated with these therapies.

The tender, with a budget of €4.2 million, invites companies and organizations to submit proposals for the preclinical development of a new drug based on advanced therapies. The aim is to boost the fight against hematological cancers, such as acute myeloblastic leukemia and T-cell lymphoblastic leukemia, for which there are currently no effective treatments.

Promoting public-private collaboration in health

The CART_ANDALUCÍA project, co-funded by the Andalusian FEDER Operational Program 2021-2027, aims to foster collaboration between the public and private sectors. Cooperation between companies, research institutions, and the Andalusian healthcare system is expected to lead to the development of new immunotherapies that could transform the treatment of hematological tumors, and eventually, solid tumors.

The tender has been approved by the Andalusian Regional Government's Steering Committee for Public Procurement of Innovation and is being managed by the Andalusian Technical Office for Public Procurement of Innovation in Health (OT-CPISalud), together with the Andalusian Network for the Design and Translation of Advanced Therapies (Radytta) of the Progress and Health Foundation.

Interested companies may submit their proposals until April 10, 2025. Detailed tender documents are available in the Andalusian Regional Government's Contracting Profile.

Tags: CancerSpainInvestmentFront page
Previous Post

United Kingdom: Government unveils measures to streamline NHS and reduce waiting times

Next Post

Andalusia supports research into the rare disease NEDAMSS with 15,000 euros

Related Stories

A doctor in a white coat writes on a sheet of paper while a stethoscope and medication bottles are visible on the table.
Health

What is vortioxetine and what is this antidepressant prescribed for?

October 7, 2025
A woman with brown hair sits, listening attentively to a dark-skinned female doctor in a white coat, who is talking animatedly in front of a table with a laptop, in a modern office with beige walls and a circular mirror on the wall.
Health

Ketoconazole Shampoo: How to Use It Correctly for Dandruff and Dermatitis?

October 6, 2025
A variety of pills and capsules of different colors and shapes, including white, orange, and green tablets, arranged on a clear surface.
Health

What is the best time to take Hydroferol to absorb it better?

October 3, 2025
A man sitting opposite a doctor wearing a white coat and stethoscope in an office with a table, a tablet, and several medication bottles visible. The doctor appears to be explaining something to the patient.
Health

Mupirocin vs. Fucidin: Which is Better for Skin Infections?

September 29, 2025
Load More

Most Shared

  • A person holds a blue injection device in their hands, with an additional cartridge and several disposable needles on a wooden table.

    Ozempic in Spain: How much does it cost and how to get it?

    2 shared
    Share 1 Tweet 1
  • Mounjaro in Spain: When did it arrive and what's its price?

    4 shared
    Share 2 Tweet 1
  • Can I mix Enantyum and Paracetamol if the pain is very severe?

    2 shared
    Share 1 Tweet 1
  • Dexketoprofen vs. Ibuprofen: Which is better for pain?

    1 shared
    Share 0 Tweet 0
  • Can Ozempic be purchased without a prescription at pharmacies in Spain?

    0 shares
    Share 0 Tweet 0

logo for Vitals Today, your trusted source for health news, a green heart with the words Vitals Today, all in green

Vitals Today, your trusted source for healthcare news. Stay updated on the latest studies, regulations, and industry initiatives.

  • LinkedIn
  • X
  • Bluesky
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Legal Notice
  • Contact

© 2024 Vitals Today - all rights reserved

Manage consent

To deliver the best experiences, we use technologies such as cookies to store and/or access device information. Accepting these technologies will allow us to process data such as browsing behavior or unique identifiers on this site. Not accepting or withdrawing consent may negatively impact certain features and functionality.

Functional Always active
Technical storage or access is strictly necessary for the legitimate purpose of allowing the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Storage or technical access used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
Technical storage or access is necessary to create user profiles for the purpose of sending advertising, or to track the user on a website or across multiple websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
No Result
View All Results
  • Portal
  • Breaking News
  • Policy
  • Studies
  • Companies
  • Professionals
  • Español
    • English
    • Español

© 2024 Vitals Today - all rights reserved